Metabolic response to radiation therapy in cancer

2021 ◽  
Author(s):  
Graham H. Read ◽  
Justine Bailleul ◽  
Erina Vlashi ◽  
Aparna H. Kesarwala
Keyword(s):  
Radiation Therapy ◽  
Metabolic Response

Complete metabolic response after definitive radiation therapy for cervical cancer: Patterns and factors predicting for recurrence

2012 ◽  
Vol 127 (2) ◽  
pp. 303-306 ◽  
Author(s):  
Sushil Beriwal ◽  
Neeta Kannan ◽  
Paniti Sukumvanich ◽  
Scott D. Richard ◽  
Joseph L. Kelley ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Radiation Therapy ◽  
Metabolic Response ◽  
Complete Metabolic Response

Metabolic response to radiation therapy in patients with cancer

Metabolism ◽  
1996 ◽  
Vol 45 (6) ◽  
pp. 767-773 ◽  
Author(s):  
Samuel Klein ◽  
Kham Luu ◽  
Yoichi Sakurai ◽  
Robert Miller ◽  
Mark Langer ◽  
...  
Keyword(s):  
Radiation Therapy ◽  
Metabolic Response ◽  
Patients With Cancer

Consolidation Radiation Therapy for Patients With Advanced Hodgkin Lymphoma in Complete Metabolic Response According to PET-CT or Gallium Imaging

2018 ◽  
Vol 18 (2) ◽  
pp. 145-151 ◽  
Author(s):  
Erin J. Song ◽  
Jordan Torok ◽  
Yuan Wu ◽  
Junzo Chino ◽  
Leonard R. Prosnitz ◽  
...  
Keyword(s):  
Radiation Therapy ◽  
Hodgkin Lymphoma ◽  
Metabolic Response ◽  
Complete Metabolic Response ◽  
Pet Ct

scholarly journals QUAD shot: an effective cyclical hypofractionated palliative radiotherapy for salivary gland carcinoma

2020 ◽  
Vol 6 (4) ◽  
pp. 20190132
Author(s):  
Ryo Toya ◽  
Tetsuo Saito ◽  
Tomohiko Matsuyama ◽  
Takahiro Watakabe ◽  
Kohsei Yamaguchi ◽  
...  
Keyword(s):  
Radiation Therapy ◽  
Salivary Gland ◽  
Metabolic Response ◽  
Clinical Stage ◽  
Radiation Therapy Oncology Group ◽  
Volumetric Modulated Arc Therapy ◽  
Palliative Radiotherapy ◽  
Salivary Gland Carcinoma ◽  
Oncology Group ◽  
Gland Carcinoma

Surgery with or without post-operative radiotherapy is the mainstay treatment for salivary gland carcinoma (SGC); however, palliative radiotherapy or supportive observation is considered for elderly patients. An 87-year-old female who was diagnosed with SGC in the left parotid gland, with a clinical stage T4aN2bM0 Stage IVA, underwent the Radiation Therapy Oncology Group 8502 “QUAD shot” regimen (14.8 Gy/4 fractions, twice-daily treatment with a 6 h interval, on 2 consecutive days), which were repeated every 4 weeks 3 times using volumetric modulated arc therapy. During and after the treatment, she experienced no acute toxicity but had Grade 1 xerostomia. At 4 months after completion of the treatment, [18F]-fluoro-2-deoxy-D-glucose positron emission tomography/CT revealed a complete metabolic response to the treatment. She is still alive without any evidence of recurrence 9 months after completion of the treatment. The Radiation Therapy Oncology Group 8502 “QUAD shot” regimen using VMAT may be an effective palliative treatment for SGC with minimal toxicity.

Sign in / Sign up

Export Citation Format

Share Document